Knowledge Distillery

Show all
Meta-analysis Systematic Review
Randomised double-blinded placebo-controlled trial
Interventional study with open label/non-randomised methodology
Observational study: prospective longitudinal cohort
Cross-sectional case-control studies
Case series/case reports
Expert opinion
Literature Review
Miscellaneous

Filter the news according their assigned tags.

26.07.2021 | Interventional study with open label/non-randomised methodology

The efficacy of interleukin-6 receptor antagonists in critically ill patients with COVID-19 is unclear. In this article the authors evaluated…

more...

14.07.2021 | Randomised double-blinded placebo-controlled trial

COVID-19 is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal…

more...

Knowledge Distillery

Interleukin-6 receptor antagonists in critically ill patients with covid-19

Tocilizumab in hospitalized patients with severe COVID-19 pneumonia